<doc>
  <docmeta id="113sres57ats">
    <bill congress="113" type="sres" number="57" version="ats"/>
    <revision size="3780" annotations="0" status="complete" id="4" commit-time="2013-08-10T23:15:18Z" committer="mbohmer" doc="113sres57ats/4.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <resolution xmlns:cato="http://namespaces.cato.org/catoxml" public-private="public" resolution-stage="Agreed-to-Senate" resolution-type="senate-resolution">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 SRES 57 ATS: Designating February 28, 2013, as “Rare Disease Day”.</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2013-02-26</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">III</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. RES. 57</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20130226">February 26, 2013</action-date>
			<action-desc>
        <sponsor name-id="S307">Mr. Brown</sponsor> (for himself,
			 <cosponsor name-id="S317">Mr. Barrasso</cosponsor>, <cosponsor name-id="S316">Mr. Whitehouse</cosponsor>, <cosponsor name-id="S295">Mr.
			 Pryor</cosponsor>, and <cosponsor name-id="S320">Mrs. Hagan</cosponsor>)
			 submitted the following resolution; which was considered and agreed
			 to</action-desc>
		</action>
		<legis-type>RESOLUTION</legis-type>
		<official-title display="yes">Designating February 28, 2013, as
		  <quote>Rare Disease Day</quote>.</official-title>
	</form>
	<preamble>
		<whereas>
      <text>Whereas rare diseases and disorders are those that affect
			 a small number of patients, typically less than 200,000 people in the United
			 States;</text>
		</whereas>
    <whereas>
      <text>Whereas, as of the date of approval of this resolution,
			 nearly 7,000 rare diseases affect approximately 30,000,000 people in the United
			 States and their families;</text>
		</whereas>
    <whereas>
      <text>Whereas children with rare genetic diseases account for
			 more than half of the population affected by rare diseases in the United
			 States;</text>
		</whereas>
    <whereas>
      <text>Whereas many rare diseases are serious, life-threatening,
			 and lack an effective treatment;</text>
		</whereas>
    <whereas>
      <text>Whereas rare diseases and conditions include epidermolysis
			 bullosa, progeria, sickle cell anemia, Tay-Sachs, cystic fibrosis, many
			 childhood cancers, and fibrodysplasia ossificans progressiva;</text>
		</whereas>
    <whereas>
      <text>Whereas people with rare diseases experience challenges
			 that include difficulty in obtaining an accurate diagnosis, limited treatment
			 options, and difficulty finding physicians or treatment centers with expertise
			 in their diseases;</text>
		</whereas>
    <whereas>
      <text>Whereas great strides have been made in research and
			 treatment for rare diseases as a result of the <cato:entity entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Orphan Drug Act">Orphan Drug Act</cato:entity-ref> (<cato:entity-ref entity-type="public-law" value="public-law/97/414">Public Law
			 97–414</cato:entity-ref>; <cato:entity-ref entity-type="statute-at-large" value="statute-at-large/96/2049">96 Stat. 2049</cato:entity-ref>)</cato:entity> and amendments made by that Act;</text>
		</whereas>
    <whereas>
      <text>Whereas 2013 marks the 30th anniversary of the <cato:entity-ref entity-type="act" value="Orphan Drug Act">Orphan Drug
			 Act</cato:entity-ref> and therefore a time to reflect upon the successes of that Act and the
			 challenges to be addressed in the future;</text>
		</whereas>
    <whereas>
      <text>Whereas both the <cato:entity-ref entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> and the <cato:entity-ref entity-type="federal-body" entity-id="7529">National Institutes of Health</cato:entity-ref> have established special offices to advocate for rare disease research and treatments;</text>
		</whereas>
    <whereas>
      <text>Whereas the National Organization for Rare Disorders, an organization established in 1983 to provide services to, and advocate on behalf of, patients with rare diseases, was a primary force behind the enactment of the <cato:entity-ref entity-type="act" value="Orphan Drug Act">Orphan Drug Act</cato:entity-ref> and remains a critical public voice for people with rare diseases;</text>
		</whereas>
    <whereas>
      <text>Whereas the National Organization for Rare Disorders
			 sponsors Rare Disease Day in the United States to increase public awareness of
			 rare diseases;</text>
		</whereas>
    <whereas>
      <text>Whereas Rare Disease Day has become a global event
			 occurring annually on the last day of February and was observed in more than 60
			 countries in 2012;</text>
		</whereas>
    <whereas>
      <text>Whereas Rare Disease Day was observed in the United States
			 for the first time on February 28, 2009; and</text>
		</whereas>
    <whereas>
      <text>Whereas Rare Disease Day is anticipated to be observed
			 globally for years to come, providing hope and information for rare disease
			 patients around the world; Now, therefore, be it</text>
		</whereas>
  </preamble>
	<resolution-body>
		<section display-inline="yes-display-inline" id="S1" section-type="undesignated-section">
      <enum/>
      <text>That the <cato:entity-ref entity-type="federal-body" entity-id="0010">Senate</cato:entity-ref>—</text>
			<paragraph id="idC55410511D104D1A8C31D68E430A6ECC">
        <enum>(1)</enum>
        <text>designates
			 February 28, 2013, as <quote>Rare Disease Day</quote>;</text>
			</paragraph>
      <paragraph id="id75321ADA42FB4830B494096A682386CF">
        <enum>(2)</enum>
        <text>recognizes the
			 importance of improving awareness and encouraging accurate and early diagnosis
			 of rare diseases and disorders; and</text>
			</paragraph>
      <paragraph id="id15160B257F7E45D18B1134690FA53BC6">
        <enum>(3)</enum>
        <text>supports a
			 national and global commitment to improving access to, and developing new
			 treatments, diagnostics, and cures for, rare diseases and disorders.</text>
			</paragraph>
    </section>
  </resolution-body>
</resolution>
</doc>